The Drugs Controller General of India (DCGI) on Tuesday imposed an emergency ban on India’s first locally manufactured mRNA vaccine against COVID-19 for people 18 years of age or older developed by Genoa Biopharmaceuticals. Approved for use, official sources said Tuesday. While other MRNA vaccines need to be stored at zero temperature, Genoa’s MRNA vaccine can be stored at 2-8 degrees, an official source told PTI. The drug regulator has also approved the Serum Institute’s COVID-19 vaccine Covovax for limited emergency use in children aged 7 to 11 with certain conditions.
DCGI’s approval came after CSDCO’s subject matter expert committee on COVID-19 last week recommended that Covovax be used as an emergency for the 7- to 11-year-old age group, and Gennova’s 18-year-old and Two doses of the M-RNA vaccine for more than that, official sources said. Official sources said that Prakash Kumar Singh, Director, Government and Regulatory Affairs, Serum Institute of India (SII), had submitted a petition to DCGI on March 16 in this regard. The expert panel, at its last meeting in April, had sought more data from the Pune firm on request.
DCGI approved Covovax on December 28 for limited use in adults and the 12- to 17-year-old age group on March 9, subject to certain conditions. The country started vaccinating 12-14 year olds from March 16. The campaign was launched on January 16 last year, with the first phase of vaccinating healthcare workers. Frontline workers were vaccinated on February 2 last year.
The next phase of the COVID-19 vaccination began on March 1 last year with specific adaptation conditions for people over 60 and those aged 45 and over. India started vaccinating all people over the age of 45 from April 1 last year. The government then decided to increase its vaccination campaign by allowing everyone over the age of 18 to be vaccinated against the virus from May 1 last year. The next phase of vaccination started on January 3 for young people aged 15-18.
From January 10, India started giving immunization vaccines to healthcare and frontline workers and people aged 60 years and above. The precautionary dose of the COVID-19 vaccine for all people over the age of 18 began on April 10.
Read all the latest news, breaking news, top videos and live TV here.